Answers are grounded in this paper and cite their sources.
Background Acute autoimmune glial fibrillary acidic protein astrocytopathy (GFAP-A) exhibits wide clinical heterogeneity; some patients develop life-threatening critical illness, whose correlates remain poorly defined. This retrospective pilot study explored clinical, laboratory and radiological factors associated with critical illness in acute GFAP-A. Methods Thirty-two acute GFAP-A patients were enrolled (7 with critically ill status, 25 non-critically ill). Critically ill status was defined as acute-onset status epilepticus or respiratory failure requiring mechanical ventilation. Between-group comparisons were conducted using the Mann-Whitney U test and Fisher’s exact test with effect-size estimation. Results Fever and headache were comparable across groups. Critically ill patients had higher rates of disturbance of consciousness and urinary retention, with a marginal trend for limb paralysis, whereas psychiatric abnormalities, sporadic seizures and tremor showed no intergroup differences. They also exhibited higher monocyte count and monocyte-to-lymphocyte ratio(MLR), lower serum sodium and chloride levels, higher intracranial pressure, elevated CSF protein levels, reduced serum free triiodothyronine(T3), and a higher prevalence of non-thyroidal illness syndrome(NTIS). Neutrophil-to-lymphocyte ratio(NLR), systemic immune-inflammation index(SII) and CSF Epstein-Barr virus(EBV) sequence detection were similar between groups. MRI lesion distribution showed no significant difference, although brainstem, spinal cord and cerebral parenchymal involvement appeared more frequent among critically ill patients. Conclusions Elevated admission mRS, lower serum sodium, chloride and T3 levels, raised intracranial pressure and CSF protein, higher monocyte counts, MLR and NTIS prevalence are key correlates of critically ill status in acute GFAP-A. Disturbance of consciousness and urinary retention are important clinical phenotypes of critical illness. Trends in neuroimaging await larger-cohort validation. These preliminary findings identify candidate clinical-laboratory features for future development of early risk-stratification tools.
No takes yet. Share an insight, caveat, or question.
Huang et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: